CN Patent

CN105056211A — 治疗糖尿病和降低体重的毒蜥外泌肽

Assigned to Amylin Pharmaceuticals LLC · Expires 2015-11-18 · 10y expired

What this patent protects

本发明提供通过使用毒蜥外泌肽、毒蜥外泌肽激动剂或毒蜥外泌肽类似物激动剂来降低体重、改变身体组成、治疗糖尿病、降低HbA 1c 和降低平均每日血糖的方法。

USPTO Abstract

本发明提供通过使用毒蜥外泌肽、毒蜥外泌肽激动剂或毒蜥外泌肽类似物激动剂来降低体重、改变身体组成、治疗糖尿病、降低HbA 1c 和降低平均每日血糖的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN105056211A
Jurisdiction: CN
Classification: —
Expires: 2015-11-18
Drug substance claim: No
Drug product claim: No
Assignee: Amylin Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.